MANAGE YOUR RX
Contact Us

Rositara Gel

NDC:

72934-1533-02

SKNV Code:

171083
Formulation:
NIACINAMIDE 4% / IVERMECTIN 1% / METRONIDAZOLE 1%
Common Usage:
Rosacea
Packaging:
30 ML AIRLESS PUMP
VIEW ALL MEDICATIONS
Rositara Gel 30ml airless pump – Ivermectin 1% Metronidazole 1% Niacinamide 4% compounded by SKNV Pharmacy
Previously known as Aveidaoxia Gel
Rositara Gel combines niacinamide 4%, ivermectin 1%, metronidazole 1%, and potassium azeloyl diglycinate 30% in a provider-prescribed formula targeting rosacea and persistent skin redness. Ivermectin and metronidazole address redness, visible blood vessels, flushing, and pustules at the source, while niacinamide and potassium azeloyl diglycinate soothe and even the complexion. A multi-ingredient option for patients looking for clinically guided relief from rosacea symptoms.

Quality Without Compromise

Medications without potential allergens or irritants for certain patients, as determined by your provider*

How to Send a 

Rositara Gel

Prescription Through Your EMR

1. Select ‘SKNV Pharmacy’ in the prescribing section of your EMR.
2. Enter '
Rositara Gel
' in your EMR.

3. Enter the SKNV medication name found in column 1. 

All medications are already loaded in your EMR.

You can locate SKNV in your EMR by one of the following:

  • Name – SKNV Pharmacy
  • NCPDP: 5754634
  • NABP: 1726341
  • City: Deerfield Beach
  • ZIP code:  33442
4. Make sure the patient’s cell phone is the primary contact in your EMR, then submit the prescription.

Let your patient know they will receive a text message to pay for the prescription.

Once payment is made and the RX is dispensed, the patient will receive a text message with the tracking information.

Discover the full range of SKNV medications available for your patients. Explore our complete catalog to find the right solution for your practice and patient needs.

VIEW ALL SKNV MEDICATIONS

These medications are made by SKNV, an FDA-registered 503B outsourcing facility that specializes in customized medications to meet unique patient needs. The prescribing doctor will determine if the medication makes a clinical difference for the individual patient. The FDA does not review medications made in an outsourcing facility for any particular indication, safety or efficacy. SKNV makes no claims its customized medications are safer or more efficacious than a commercially available drug. Any references to “common usages” should not be interpreted as recommendations or claims regarding the clinical indication of any medication.